Adolescents and young adults Archives

April 24, 2025

April 24, 2025

Trial Spotlight: A Closer Look at ECOG-ACRIN’s Studies for Adolescents and Young Adults with Cancer

These two trials are open and enrolling adolescent and young adult survivors and patients with cancer

October 19, 2023

Now Enrolling: Social Genomics Study EAQ211 to Examine Known Biomarkers of Elevated Health Risk in Adolescent and Young Adult Cancer Survivors

Through a series of blood tests and patient questionnaires, this prospective observational study examines how exposures to trauma and other adverse life experiences alter the activity of genes, immune cells, and subsequent health outcomes

November 16, 2021

November 16, 2021

Now Enrolling: EAQ202 to Improve Adolescent and Young Adult Self-Reported Data

This pilot study is determining the feasibility and acceptability for adult and young adult participants patients between the ages of 18 and 39 in ECOG-ACRIN treatment trials to use the National Institutes of Health’s Patient-Reported Outcomes Measurement Information System (PROMIS®)